概括
解决治疗中的差异需要理解和克服诸如无意识偏见和缺乏多样性的障碍. 促进研究和医疗保健的包容性对于改善所有患者的结果至关重要.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
背景情况:
- 管理方面的进步并没有消除许多人的显著差异和缺乏包容性.
- 医疗保健提供者,研究参与者和研究人员之间缺乏多样性加剧了的发病率和死亡率.
- 最近的社会正义运动和主要卫生组织的倡议凸显了解决这些不平等问题的必要性.
研究的目的:
- 探讨病护理中的差异和缺乏包容性的多方面的问题.
- 确定阻碍获得及时有效治疗的社会人口结构障碍.
- 讨论改善管理和研究中的健康平等和包容性的潜在解决方案.
主要方法:
- 文献综述和综合关于症护理差异的当前研究.
- 对影响患者获得医疗保健的社会人口统计因素的分析.
- 探索患者倡导团体和管理机构提出的倡议.
主要成果:
- 确定了历史决定因素,无意识的偏见和缺乏多样性的关键障碍,以实现公平的治疗.
- 强调公共卫生研究在揭露医疗保健缺陷方面的作用.
- 强调,对差距和技术进步的提高意识可以促进更好的健康公平.
结论:
- 提高认识和促进参与研究的多样性对于促进服务不足人群的治疗至关重要.
- 解决无意识的偏见和历史决定因素对于建立信任和提供有效护理至关重要.
- 在治疗和研究的各个方面促进更大的包容性对于减少发病率和死亡率至关重要.
相关概念视频
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Seizures: Classification
299
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
299
Antiepileptic Drugs: Glutamate Antagonists
271
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
271
Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
Antiepileptic Drugs: Sodium Channel Blockers
359
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
359
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142


